Immune Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$17,889,000 over the previous period. Total operating expenses were $4,384,000.
Profit Margin
| 2010 | 994K | -15.53M | -1563.08% |
|---|---|---|---|
| 2011 | 944K | -15.65M | -1658.47% |
| 2012 | 7.80M | -2.57M | -32.97% |
| 2013 | 19K | -5.76M | -30315.79% |
| 2014 | 2K | -23.55M | -1177500% |
| 2015 | 0 | -17.15M | |
| 2016 | 0 | -32.66M | |
| 2017 | 0 | -17.88M |
IMNP Income Statement (2010 – 2017)
| 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||
Revenue | 0 | 0 | 0 | 2K | 19K | 7.80M | 944K | 994K |
Cost of revenue | 0 | 0 | 0 | 20K | 0 | 403K | 692K | 997K |
Gross profit | 0 | 0 | 0 | -18K | 19K | 7.40M | 252K | -3K |
Operating exp. | ||||||||
Research and development | 5.51M | 8.33M | 5.93M | 5.64M | 3.57M | 3.4M | 7.85M | 8.12M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 4.38M | 17.00M | 14.29M | 12.96M | 13.12M | 10.90M | 14.30M | 15.37M |
Operating income | -12.12M | -27.26M | -15.72M | -16.36M | -9M | -606K | -14.05M | -15.37M |
Other income (expenses), net | -7.73M | -10.25M | -1.43M | -7.18M | 3.25M | -1.96M | 1.59M | 159K |
Income before tax | -19.86M | -37.51M | -17.15M | -23.55M | -5.74M | -2.57M | -15.65M | -15.53M |
Income tax expense | -1.97M | -4.85M | -606K | -3.78M | 11K | 2K | 4K | -4K |
Net income | -17.88M | -32.66M | -17.15M | -23.55M | -5.76M | -2.57M | -15.65M | -15.53M |
Earnings per share | ||||||||
Basic EPS | -0.52 | -0.95 | -0.5 | -0.96 | -0.41 | -0.02 | -0.22 | -0.32 |
Diluted EPS | -1.52 | -7.7 | -0.5 | -1.41 | -0.81 | -0.03 | -0.22 | -0.32 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |